Target Name: TRIM49
NCBI ID: G57093
Review Report on TRIM49 Target / Biomarker Content of Review Report on TRIM49 Target / Biomarker
TRIM49
Other Name(s): tripartite motif containing 49 | RING finger protein 18 | TRI49_HUMAN | Tripartite motif containing 49 | Tripartite motif-containing protein 49 | testis-specific RING Finger protein | testis-specific ring-finger protein | RNF18 | tripartite motif-containing protein 49 | Testis-specific RING-finger protein | TRIM49L2 | ring finger protein 18 | tripartite motif-containing 49 | TRIM49A

TRIM49: A Potential Drug Target and Biomarker

TRIM49, a protein, is found in a variety of tumor cells and is considered a potential drug target. By studying the function and structure of TRIM49, we can better understand its role in tumor development and provide new ideas for studying cancer treatment.

TRIM49 is a protein composed of three subunits, each consisting of approximately 200 amino acids. Its structure shows a special T-shape, with two subunits located above the T and the third subunit located below the T. This structure allows TRIM49 to interact with other proteins in cells to exert its function.

TRIM49 is expressed in various tumor cells

TRIM49 is expressed in a variety of tumor cells, including breast cancer, lung cancer, prostate cancer and lymphoma. In breast cancer, the expression level of TRIM49 is positively correlated with disease progression and invasion ability. In lung cancer, the expression level of TRIM49 is positively correlated with the disease invasion ability. In prostate cancer and lymphoma, TRIM49 expression levels are positively correlated with disease progression and invasiveness.

TRIM49 is involved in tumor cell growth and progression

TRIM49 plays an important role in the growth and progression of tumor cells. Studies have shown that TRIM49 can promote the growth and angiogenesis of tumor cells, thereby providing sufficient nutrients and oxygen to tumors. In addition, TRIM49 can also inhibit the apoptosis of tumor cells, thereby delaying the progression of tumor cells.

TRIM49 is associated with immune evasion of tumor cells

TRIM49 plays an important role in immune evasion of tumor cells. Tumor cells are usually able to evade immune system attack in a variety of ways, including inhibiting the interaction between immune cells and tumor cells and inhibiting the proliferation and differentiation of immune cells. TRIM49 may help tumor cells evade immune surveillance through its special structure and function.

Biological functions and pharmacological significance of TRIM49

TRIM49, as a protein with unique structure and function, is of great significance in tumor biology and pharmacology research. Through in-depth study of the structure and function of TRIM49, we can better understand the development and progression of tumor cells and provide new ideas for tumor treatment.

TRIM49, as a protein, plays an important role in the development and progression of tumor cells. In-depth study of the structure and function of TRIM49 can provide new ideas for tumor treatment and is expected to become a new drug target.

Protein Name: Tripartite Motif Containing 49

The "TRIM49 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRIM49 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TRIM49B | TRIM49C | TRIM49D2 | TRIM5 | TRIM50 | TRIM51 | TRIM51EP | TRIM51G | TRIM51HP | TRIM52 | TRIM53AP | TRIM54 | TRIM55 | TRIM56 | TRIM58 | TRIM59 | TRIM59-IFT80 | TRIM6 | TRIM6-TRIM34 | TRIM60 | TRIM60P15 | TRIM61 | TRIM62 | TRIM63 | TRIM64 | TRIM64B | TRIM64C | TRIM65 | TRIM66 | TRIM67 | TRIM68 | TRIM69 | TRIM7 | TRIM7-AS2 | TRIM71 | TRIM72 | TRIM73 | TRIM74 | TRIM75 | TRIM77 | TRIM8 | TRIM9 | TRIML1 | TRIML2 | TRIO | TRIOBP | TRIP10 | TRIP11 | TRIP12 | TRIP13 | TRIP4 | TRIP6 | Tripartite motif containing 78, pseudogene | TRIQK | TRIR | TRIT1 | TRL-AAG1-2 | TRL-AAG2-3 | TRL-TAG2-1 | TRMO | TRMT1 | TRMT10A | TRMT10B | TRMT10C | TRMT11 | TRMT112 | TRMT12 | TRMT13 | TRMT1L | TRMT2A | TRMT2B | TRMT44 | TRMT5 | TRMT6 | TRMT61A | TRMT61B | TRMT9B | TRMU | TRN-GTT4-1 | TRNA | tRNA splicing endonuclease complex | tRNA(Sec) complex | tRNA-splicing endonuclease complex | tRNA-splicing ligase complex | TRNAU1AP | TRNC | TRND | TRNE | TRNF | TRNG | TRNH | TRNI | TRNK | TRNL1 | TRNL2 | TRNM | TRNN | TRNP | TRNP1 | TRNQ